The Effect of Continuation of Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Before Kidney Transplantation

被引:0
|
作者
Baek, C. [1 ]
Kim, H. [1 ]
Park, S. [2 ]
机构
[1] Asan Med Ctr, Seoul, South Korea
[2] Asan Med Ctr, Coll Med, Seoul 138736, South Korea
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
A223
引用
下载
收藏
页码:S708 / S709
页数:2
相关论文
共 50 条
  • [1] Should We Discontinue Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Before Kidney Transplantation?
    Baek, Chung Hee
    Kim, Hyosang
    Park, Su-Kil
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 835 - 835
  • [2] Acute effect of angiotensin II receptor blocker and angiotensin converting enzyme inhibitor on baroreflex
    Shimizu, M
    Mochizuki, T
    Sasaoka, T
    Kurosawa, T
    Kurokawa, S
    Tsuyusaki, T
    Izumi, T
    JOURNAL OF HYPERTENSION, 2000, 18 : S232 - S232
  • [3] Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
    Lee, Hyun Woo
    Suh, Jae Kyung
    Jang, Eunjin
    Lee, Sang-Min
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (02): : 371 - 381
  • [4] Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease
    Molnar, Miklos Z.
    Kalantar-Zadeh, Kamyar
    Lott, Evan H.
    Lu, Jun Ling
    Malakauskas, Sandra M.
    Ma, Jennie Z.
    Quarles, Darryl L.
    Kovesdy, Csaba P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (07) : 650 - 658
  • [5] Paradoxical pressor response with angiotensin-converting enzyme inhibitor and angiotensin receptor blocker
    Sabitha, P.
    Adhikari, Prabha M.
    AUSTRALASIAN MEDICAL JOURNAL, 2011, 4 (07): : 364 - +
  • [6] Effects of combination therapy of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker
    Idrizi, A
    Gjata, M
    Barbullushi, M
    Koroshi, A
    Tase, M
    Sadiku, E
    Hoti, K
    JOURNAL OF HYPERTENSION, 2005, 23 : S398 - S398
  • [7] Kidney Outcomes Following Angiotensin Receptor-Neprilysin Inhibitor vs Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy for Thrombotic Microangiopathy
    Li, Jianbo
    Liu, Qinghua
    Lian, Xingji
    Yang, Shicong
    Lian, Rong
    Li, Wenchuan
    Yu, Jianwen
    Huang, Fengxian
    Chen, Wenfang
    He, Feng
    Chen, Wei
    JAMA NETWORK OPEN, 2024, 7 (09)
  • [8] Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease
    Chen, Ping-Min
    Lai, Tai-Shuan
    Chen, Ping-Yu
    Lai, Chun-Fu
    Wu, VinCent
    Chiang, Wen-Chih
    Chen, Yung-Ming
    Wu, Kwan-Dun
    Tsai, Tun-Jun
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2014, 113 (04) : 219 - 226
  • [9] Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury
    Brar, Sandeep
    Ye, Feng
    James, Matthew T.
    Hemmelgarn, Brenda
    Klarenbach, Scott
    Pannu, Neesh
    JAMA INTERNAL MEDICINE, 2018, 178 (12) : 1681 - 1690
  • [10] Combined treatment of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker in kidney transplant recipients with persistent proteinuria
    Tuncer, M
    Kocak, H
    Yavuz, A
    Karatas, GU
    Erdogan, O
    Gurkan, A
    Dinckan, A
    Ersoy, F
    Yakupoglu, G
    Demirbas, A
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V15 - V15